Search research articles
Contact Us
Filters
Showing results (11-20 of 119) with videos related to
Page
of 12
Sort By:
Journal of Molecular and Cellular Cardiology
|
October 4, 2005
Unraveling the mysteries of classical preconditioning
James M Downey, Michael V Cohen
Progress in Cardiovascular Diseases
|
April 22, 2006
Reducing infarct size in the setting of acute myocardial infarction
James M Downey, Michael V Cohen
Circulation Journal : Official Journal of the Japanese Circulation Society
|
June 10, 2009
Why do we still not have cardioprotective drugs?
James M Downey, Michael V Cohen
Journal of Cardiovascular Pharmacology and Therapeutics
|
October 25, 2019
What Are Optimal P2Y12 Inhibitor and Schedule of Administration in Patients With Acute Coronary Syndrome?
Michael V Cohen, James M Downey
Basic Research in Cardiology
|
February 17, 2006
A really radical observation--a comment on Penna et al. in Basic Res Cardiol (2006) 101:180-189
James M Downey, Michael V Cohen
Journal of Cardiovascular Pharmacology and Therapeutics
|
December 4, 2013
Combined cardioprotectant and antithrombotic actions of platelet P2Y12 receptor antagonists in acute coronary syndrome: just what the doctor ordered
Michael V Cohen, James M Downey
Basic Research in Cardiology
|
September 28, 2017
The impact of irreproducibility and competing protection from P2Y<sub>12</sub> antagonists on the discovery of cardioprotective interventions
Michael V Cohen, James M Downey
Expert Review of Cardiovascular Therapy
|
May 31, 2008
Free radicals in the heart: friend or foe?
James M Downey, Michael V Cohen
Circulation
|
January 20, 2005
We think we see a pattern emerging here
James M Downey, Michael V Cohen
Journal of the American College of Cardiology
|
February 24, 2009
Adenosine at reperfusion: a conundrum ready to be resolved
Michael V Cohen, James M Downey
Page
of 12
Search research articles
Search
Showing results (11-20 of 119) with videos related to
Sort By:
Page
of 12
Journal of Molecular and Cellular Cardiology
|
October 4, 2005
Unraveling the mysteries of classical preconditioning
James M Downey, Michael V Cohen
Progress in Cardiovascular Diseases
|
April 22, 2006
Reducing infarct size in the setting of acute myocardial infarction
James M Downey, Michael V Cohen
Circulation Journal : Official Journal of the Japanese Circulation Society
|
June 10, 2009
Why do we still not have cardioprotective drugs?
James M Downey, Michael V Cohen
Journal of Cardiovascular Pharmacology and Therapeutics
|
October 25, 2019
What Are Optimal P2Y12 Inhibitor and Schedule of Administration in Patients With Acute Coronary Syndrome?
Michael V Cohen, James M Downey
Basic Research in Cardiology
|
February 17, 2006
A really radical observation--a comment on Penna et al. in Basic Res Cardiol (2006) 101:180-189
James M Downey, Michael V Cohen
Journal of Cardiovascular Pharmacology and Therapeutics
|
December 4, 2013
Combined cardioprotectant and antithrombotic actions of platelet P2Y12 receptor antagonists in acute coronary syndrome: just what the doctor ordered
Michael V Cohen, James M Downey
Basic Research in Cardiology
|
September 28, 2017
The impact of irreproducibility and competing protection from P2Y<sub>12</sub> antagonists on the discovery of cardioprotective interventions
Michael V Cohen, James M Downey
Expert Review of Cardiovascular Therapy
|
May 31, 2008
Free radicals in the heart: friend or foe?
James M Downey, Michael V Cohen
Circulation
|
January 20, 2005
We think we see a pattern emerging here
James M Downey, Michael V Cohen
Journal of the American College of Cardiology
|
February 24, 2009
Adenosine at reperfusion: a conundrum ready to be resolved
Michael V Cohen, James M Downey
Page
of 12